Monday, July 28, 2014

Caregivers and healthcare professionals, here is some great information

Here is a great dementia resource for caregivers and healthcare professionals,

Your residents will love the Amazon Kindle Fire

Here is information on being the best caregiver you can be

Here is a way for nurses administrators, social workers and other health care professionals to get an easyceu or two

Follow alzheimersideas on twitter

Dementia Caregiver's Little Book of Hope [Kindle

Johns Hopkins News Alert
 
The brain contains about 100 billion neurons. A common misconception is that tens of thousands of neurons die each day. In reality, few neurons die over a person's lifetime, but they do shrink. This shrinkage may partially explain why mental functioning slows in middle and older age. (Serious memory problems do occur when major disorders such as a stroke or Alzheimer's destroy whole clusters of neurons.)
In addition to the shrinkage of neurons, starting in middle age the brain begins producing smaller quantities of many neurotransmitters -- chemical messengers that relay information between nerve cells. Brain blood flow is also reduced 15 to 20 percent between ages 30 and 70, although the shrinkage of neurons may account for the reduced flow because less tissue requires less blood.
Cultural attitudes and preconceptions about aging and memory loss can also influence the occurrence of memory lapses as people age. In one study, researchers compared the memory skills of two groups known to harbor few stereotypes concerning old age -- the people of China and deaf Americans -- with those of a third group known to have numerous preconceptions about aging, hearing Americans. Among these preconceptions is the notion that aging causes an inevitable decline in memory skills.
The study results suggest that there is a strong link between culture and memory: The first two groups were less forgetful than the third group, and older Chinese participants performed as well as the younger people in each of these groups. The implication is that if people expect their memory to get worse, they may be less diligent in trying to remember.
Other research indicates that the mental processes required to remember newly acquired information are the same as those needed to retrieve memories from long ago -- something most older people do quite well. This finding implies that older people retain the capacity to recall recent events, but the new information is not being recognized as important or is being discarded instead of stored.
Some researchers interpret this to mean that occasional memory lapses may result from a failure to pay close attention to the information rather than an inability to remember. Thus, it appears that forging new memories depends in large part on staying interested, active and alert.
 
 
 

Thursday, July 17, 2014

Discovery of new drug targets for memory impairment in Alzheimer's disease

Caregivers and healthcare professionals, here is some great information

Here is a great dementia resource for caregivers and healthcare professionals,


Your residents will love the Amazon Kindle Fire


Here is information on being the best caregiver you can be


Here is a way for nurses administrators, social workers and other health care professionals to get an easyceu or two


Follow alzheimersideas on twitter

The Dementia Caregiver's Little Book of Hope [Kindle

Medical Xpress
 

Research team in Korea has discovered that reactive astrocytes, which have been commonly observed in Alzheimer's patients, aberrantly and abundantly produce the chief inhibitory neurotransmitter GABA and release it through the Best1 channel. The released GABA strongly inhibits neighboring neurons to cause impairment in synaptic transmission, plasticity and memory. This discovery will open a new chapter in the development of new drugs for treating such diseases.

 Alzheimer's disease, which is the most common cause of dementia, is fatal and currently, there is no cure. In Alzheimer's disease, brain cells are damaged and destroyed, leading to devastating memory loss. It is reported that 1 in 8 Americans aged 65 or over have Alzheimer's disease. In 2011, 7,600 elderly people with dementia lost their way back home and became homeless in Korea. However, to date, there has been no clear understanding of the mechanisms underlying dementia in Alzheimer's disease. So far, neuronal death is the only proposed mechanism available in scientific literature.

The research team led by Dr. C. Justin Lee at Korea Institute of Science and Technology (KIST) and Dr. Daesoo Kim(KAIST) discovered that reactive astrocytes in the brains of Alzheimer's disease model mice produce the inhibitory transmitter GABA by the enzyme Monoamine oxidase B (MAO-B) and release GABA through the Bestrophin-1 channel to suppress normal information flow during . Based on this discovery, the team was able to reduce the production and release of GABA by inhibiting MAO-B or Bestrophin-1, and successfully ameliorate impairments in , synaptic transmission and memory in Alzheimer's disease model mice.

In the behavioral test, the team used the fact that mice tend to prefer dark places. If a mouse experiences an electric shock in a dark place, it will remember this event and avoid dark places from then on. However, a mouse with modeled Alzheimer's disease cannot remember if such shock is related to dark places and keeps going back to dark places. The team demonstrated that treating these mice with a MAO-B inhibitor fully recovered the mice's memory. The selegiline is currently used in Parkinson's disease as an adjunct therapy and considered as a one of best promising medicine for MAO-B inhibitor. But it has been previously shown to be less effective in Alzheimer's

 

Thursday, July 10, 2014

Legalizing marijuana for Alzheimer's disease

Caregivers and healthcare professionals, here is some great information

Here is a great dementia resource for caregivers and healthcare professionals,

Your residents will love the Amazon Kindle Fire

Here is information on being the best caregiver you can be

Here is a way for nurses administrators, social workers and other health care professionals to get an easyceu or two

Follow alzheimersideas on twitter

The Dementia Caregiver's Little Book of Hope [Kindle

Today only 4 percent of Alzheimer’s patients are 65 or younger, but as the baby boomer generation ages that number will dramatically increase. Five million older Americans suffer from the disease. It is the sixth leading cause of death in the United States. Unfortunately many older Americans will wonder why they should spend their golden years battling the illnesses or caring for someone who has it, when this is unnecessary because of the benefits boomers could gain in the treatment of Alzheimer’s Disease should they have access to legalized marijuana.
Scientists have made ground breaking discoveries in early detection of the disease but this does little for baby boomers who are working with older brains. Of the major deadly diseases in America, Alzheimer’s is the only illness that doctors have no way of slowing its progression, have no exact treatment that has had proven results, or a cure for the disease. When treating the disease doctors have to consider the age of the patient’s brain, according to Gary Wenk. Wenk is an expert on Alzheimer’s disease and inflammation of the brain. As a neuroscience professor at Ohio State he has studied extensively the effects of cannabis on the aging brain and inflammation. Using rats, he discovered that marijuana has positive impacts on cognitive health. “It’s worked in every rat we’ve given it to. We have some happy, intelligent old rats.”
Unfortunately that is the extent of the research. Studies like this are met with major challenges. Marijuana is legal in only two states. Cannabis is strictly prohibited in 25 states. In addition to that these studies are expensive. Professor Wenk was spending $150 per rat and spent $100,000 overall. The National Institute of Health spends far less on Alzheimer’s disease research than HIV/AIDS, cancer and heart disease research. In comparison $3-$6 billion is spent on each of the previously mentioned illnesses versus $480 million on Alzheimer’s research. Why support legal marijuana over medical marijuana for the treatment of Alzheimer’s Disease is a question that should be asked? With legal marijuana patients would not have to wait for the disease to develop in order to treat it. Legal marijuana also is heavily taxed by the government. This could indirectly create more funding for research and other programs that affect the aging population. While deaths from HIV/AIDS, cancer and heart disease decrease, deaths from Alzheimer’s disease continues to grow enormously.
Baby Boomers can change all of this. They are the demographic most heavily impacted by the illness and as half the voting population is over 45, they have the power to change the outcomes. Pined as the bell bottom wearing, war protesting pot smoking generation, it seems only natural they would be advocates of legalizing it. However, trends suggest that baby boomers are segregated. The younger generation was heavily influenced by Republican presidents Ronald Reagan and Gerald Ford. The oldest of the crowd have a tendency to lean more Democratic. Like all other generations they further differ in race, sex and socioeconomic status. This makes it hard to predict how they will behave in elections.
Perhaps one major unifying factor of this generation is community and the impact Alzheimer’s diseases will have on it. As the illness progresses it prevents seniors from enjoying the activities they participate in to remain a part of their communities. More and more seniors prefer to age at home. This is something that may not be possible when advanced dementia care is required. If baby boomers returned to their radical drug friendly roots it could open up a new level of funding for aging care, Alzheimer’s research and the treatment of the diseases that is hitting their community so hard. With these kinds of benefits it should be easy to see why legalizing marijuana would have such great benefits to baby boomers and the care they receive for Alzheimer’s Disease.
 
By Ashley Poag

 
 

Sunday, January 12, 2014

Best ways to relieve pain for those with dementia

Dementia healthcare professionals, other healthcare professionals and caregivers, here is some information you will find useful for clients and loved ones with dementia as well as others you might care for.
 
There are times when those with dementia may be in pain and they have trouble telling you, or are resistive to taking medication. One way to relieve their pain is to use  LGMedSupply Muscle Stimulators , Ultrasound Units and/or Tens Unit for relief of pain for you or for someone you care for who needs pain relief and/or rehabilitation. 
 
These devices are relatively easy to use, cost effective and do not require the patient or loved one swallow any pills which as you know can be difficult for a patient to take especially if they have dysphagia (swallowing difficulties).
 
LGMedical Supply Company is easy to deal with because they have a wide variety of the latest and greatest pain relieving supplies. They are always adding products because they have an excellent research and development team. They do not charge unreasonable rates and they are always having specials on their products. Besides this, they stand by their products, and they have an excellent customer service department. Employees of LGMedical are always willing to share product information so you can choose the right products for you, your clients or your loved one especially those with dementia.

Saturday, December 14, 2013

When do those with dementia need a nursing home-funny but true

Caregivers and healthcare professionals, here is some great information

Here is a great dementia resource for caregivers and healthcare professionals,

Your residents will love the Amazon Kindle Fire

Here is information on being the best caregiver you can be

Here is a way for nurses administrators, social workers and other health care professionals to get an easyceu or two

Follow alzheimersideas on twitter

The Dementia Caregiver's Little Book of Hope [Kindle

aging care newsletter
When you get up in the morning feeling nothing but a sense of dread and gloom, it's time for a NH!
When your mom messes and pees on the floor more than the dog, it's time for a NH!
When strangling your parent suddenly seems like a good thing, it's time for a NH!
When you clean the kitchen, look back a few minutes later, do a double take and can't remember doing it because you're so exhausted from care giving, it's time for a NH!
When you're jekyll one minute and hyde the next, it's time for a NH!
If you start going outside and cussing like a sailor to relieve stress, praying the neighbors won't think you're nuts, it's time for a NH!
When YOU start to wonder if you're nuts, it's time for a NH!
When the doc says your blood pressure is through the roof and you're on your way to a stroke, it's time for a NH!
When AC is the only socializing you've done in years, it's time for a NH!
When you're wiping your elderly parents butt more than your own, it's time for a NH!
 

Tuesday, October 22, 2013

Alzheimer's update

Caregivers and healthcare professionals, here is some great information

Here is a great dementia resource for caregivers and healthcare professionals,


Your residents will love the Amazon Kindle Fire


Here is information on being the best caregiver you can be


Here is a way for nurses administrators, social workers and other health care professionals to get an easyceu or two


Follow alzheimersideas on twitter

The Dementia Caregiver's Little Book of Hope [Kindle

Time to Step Up




Over the years we've accomplished so many things together: Passage of the National Alzheimer's Project Act (NAPA) (P.L. 111-375), the unveiling of the first-ever National Alzheimer’s Plan, enhancements to government benefits programs for individuals with Alzheimer's, introduction of critical legislation, and increased federal funding for Alzheimer’s research in the midst of challenging budgetary times. In the past year alone we've seen a host of new bipartisan co-sponsors for the HOPE for Alzheimer's Act, new members of the Congressional Task Force on Alzheimer’s Disease, dozens of town hall events, thousands of in-person meetings with elected officials, and a growing recognition of the Alzheimer's crisis among federal officials. 

By reaching out to your elected officials, via the phone and through our action alerts & petitions you've created change and made a difference in the lives of those affected by this devastating disease. You’ve repeatedly demonstrated your commitment to conquering Alzheimer's. Isn’t it time members of Congress did the same?
Tell Congress To Support Alzheimer’s Caregivers. Urge your members of Congress to support the HOPE for Alzheimer’s Act.
The Health Outcomes, Planning, and Education (HOPE) for Alzheimer's Act (S.709/H.R. 1507) will improve diagnosis of Alzheimer's disease and increase access to information on care and support for newly diagnosed individuals and their families. An early and documented diagnosis when coupled with access to care planning services leads to better outcomes for individuals with Alzheimer’s as well as their caregivers. Tell your member of Congress that families living with this devastating disease need HOPE!
Save the Date!
Mark your calendars now for the 2014 Alzheimer’s Association Advocacy Forum, taking place April 7-9 in Washington D.C. The Association’s 26th annual Forum includes the National Alzheimer's Dinner, an excellent opportunity for advocates to celebrate another exemplary year of advocacy, growing awareness and leadership in advancing Alzheimer's research and support.  Visit alz.org/forum/ to learn more about the Advocacy Forum.Advocate Mobile App on iPhoneHave you downloaded our ALZ Advocacy mobile app yet? Visit alz.org/advocateapp on your iPhone or Android device

Sunday, October 20, 2013

More Evidence Links Atrial Fibrillation and Dementia Risk

Caregivers and healthcare professionals, here is some great information

Here is a great dementia resource for caregivers and healthcare professionals,

Your residents will love the Amazon Kindle Fire

Here is information on being the best caregiver you can be

Here is a way for nurses administrators, social workers and other health care professionals to get an easyceu or two

Follow alzheimersideas on twitter

The Dementia Caregiver's Little Book of Hope [Kindle Edition

Medscape Today
Atrial fibrillation (AF) is significantly associated with cognitive impairment and dementia, independent of history of clinical stroke, a new meta-analysis has found.
Previous research had highlighted the association between AF and cognitive decline, but it was assumed that this association was mediated through clinical stroke because patients with AF are 4 to 5 times more likely to develop clinical stroke, said lead author Shadi Kalantarian, MD, MPH, research fellow, Massachusetts General Hospital Cardiac Arrhythmia Service, Boston.
"We wanted to know if this association was independent of that stroke history, and we observed that it was," he told Medscape Medical News.
The study, the first to collect and present separate data for dementia and cognitive impairment, provides the most comprehensive evidence to date of the potential effects that AF has on cognition, but also highlights "critical gaps" in understanding the mechanism underlying the association, said Dr. Kalantarian.
The study is published in the March 5 issue of the Annals of Internal Medicine.
21 Studies
Researchers searched 5 large databases — MEDLINE, PsycINFO, Cochrane Library, CINAHL, and EMBASE — as well as reference lists, with no language restrictions, for studies that reported the association between AF and cognitive impairment or total dementia.

Dr. Shadi Kalantarian
The analysis included 21 studies representing geographically diverse regions, such as Asia, North and South America, Europe, and Australia. Fourteen studies reported the association between AF and cognitive impairment or dementia in patients with or without a history of stroke, and 7 studies examined the association of AF with cognitive impairment or dementia after stroke.
In a combined analysis of the 14 studies that investigated the association between AF and dementia or cognitive impairment, 9 of which were prospective, AF was significantly associated with the risk for cognitive impairment (relative risk [RR], 1.40; 95% confidence interval [CI], 1.19 - 1.64).
There was significant heterogeneity, however, possibly due to variance in participant characteristics. With use of a random-effects model, pooled estimates were almost the same for prospective and cross-sectional studies.
Heterogeneity was still seen in prospective studies, possibly because of different outcome measures. When the analysis was restricted to dementia outcomes, which are more accurately diagnosed than cognitive impairment, the heterogeneity was eliminated but the association didn't change substantially (RR, 1.38; 95% CI, 1.22 - 1.56).
Limiting the analysis to studies using the Mini-Mental State Examination, the most widely used screening tool for cognitive decline, also did not appreciably change the results.
In the 7 studies reporting cognitive impairment or dementia after a stroke, AF was associated with a more than 2-fold increased risk (RR, 2.70; 95% CI, 1.82 - 4.00).
To evaluate the association independent of stroke history, the investigators did a meta-analysis of studies that either excluded patients with a history of stroke or adjusted for stroke in the multivariate adjusted model. For this analysis, the RR was 1.34 (95% CI, 1.13 - 1.58).
Dr. Kalantarian emphasized that the association was independent of "clinically overt stroke," that is, strokes with which patients had been diagnosed, and that they had reported.
Possible Mechanisms
Shared risk factors, such as hypertension, congestive heart failure, and diabetes, which tend to accumulate as the population ages, might explain the association between AF and cognitive decline. Another explanation could be the hypercoagulable state in patients with AF or stasis of blood in the left atrium that may lead to formation of thrombi in the left atrial appendage and then to stroke.
Other unproven mechanisms, said Dr. Kalantarian, could involve cerebral hypoperfusion — that is, less blood going to the brain might affect cognition — or the proinflammatory state in both AF and dementia.
Perhaps the most plausible explanation is that AF increases the risk for silent infarcts, which would mediate the association between AF and cognitive impairment, said Dr. Kalantarian. However, 1 study in the analysis that excluded patents with a history of stroke with detailed imaging also showed an association between AF and cognitive impairment.
"That's only 1 study in the literature, and it says that there's a gap in our knowledge," said Dr. Kalantarian. "We think that silent infarct is a major contributor, but we can't say that it's 100% the underlying mechanism and that other things are not contributing. It's probably multifactorial; that other factors are contributing as well."
Priority should be given to studies that will elucidate the underlying mechanism, she added.
The authors used several objective criteria to assess the quality of individual studies. Of the 9 prospective studies in the broader population, 6 had "reasonably good quality" in that they matched 5 or 6 of the 7 quality criteria, said Dr. Kalantarian.
However, 6 of the 21 studies met 3 or fewer quality criteria, mainly because of a higher potential for misclassification of AF or outcome, inadequate adjustments for potential confounders, and the presence of attrition bias. Sensitivity analyses that excluded these studies did report similar results, though.
Another possible limitation was that stroke was mostly self-reported or derived from medical records and rarely confirmed by imaging.
The study results warrant further well-designed longitudinal studies with better adjustment for potential confounders and with detailed information on subtype of dementia, according to the authors. As well, clinical trials to evaluate interventions that may lower the risk for cognitive impairment in patients with AF are also needed, they said.
In future trials, "investigators should consider cognitive function as a new outcome to be assessed in interventional studies for the treatment of AF," the authors write.
Critical Question
Asked to comment on these findings for Medscape Medical News, Stefan Knecht, MD, professor, neurology, St. Mauritius Therapieklinik, Meerbusch, Germany, said he's not convinced that the meta-analysis adequately answers the critical question of whether cognitive impairment is linked to something other than stroke in patients with AF.
For one thing, he said, asking patients for their history of stroke is a weak tool because if they have had "silent" strokes, they wouldn't be aware of it, and so would not report it.
. Given the propensity of AF to cause strokes, it's not clear by what means other than some sort of stroke AF would affect brain function, he pointed out.
"There are actually several questions still to be answered," he said. "What kinds of strokes occur in AF to cause cognitive impairment? How much of a problem is this? How much of this is related to the type of treatment patients receive? And what can we do about it?"
The paper simply confirms that a relationship does exist between AF and cognitive impairment, but the authors do little to disentangle possible mechanisms, added Dr. Knecht.
"Could they have done so? I think so. For example, they could have tried to sort out differences in cognitive impairments in patient with versus patients without a history of stroke."
Dr. Kalantarian noted that she and her colleagues didn't have enough data to separate out different domains of cognition.
"The methodology of cognitive assessment is so variable and not many studies look at specific domains of cognitive function," she said. "That's why we were not able to say, for example, that patients with AF are more prone to have executive dysfunction."
Dr. Kalantarian and Dr. Knecht have disclosed no relevant financial relationships.
Ann Intern Med. 2013;158:338-346. Abstract

     
    Blog Flux Directory
    alzheimersideas - whereIstand.com

    Fitness is important in dementia prevention. Click below for more info